HT
NTLA icon

HAP Trading’s Intellia Therapeutics NTLA Stock Holding History

HAP Trading’s Portfolio NTLA Stock Details NTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-11,300
Closed -$114K – 1759
2022
Q3 		$114K Buy
+11,300
New +$701K 0.01% 766
2021
Q3 		– Sell
-12,900
Closed -$35K – 2652
2021
Q2 		$35K Buy
+12,900
New +$1M ﹤0.01% 1610
2020
Q4 		– Sell
-10,600
Closed -$9K – 2383
2020
Q3 		$9K Buy
+10,600
New +$221K ﹤0.01% 1355
2020
Q2 		– Sell
-24,100
Closed -$43K – 1844
2020
Q1 		$43K Buy
24,100
+900
+4% +$12.1K ﹤0.01% 798
2019
Q4 		$25K Buy
+23,200
New +$323K ﹤0.01% 839

Other funds holding NTLA

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return